Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "2-chloropyrimidine" patented technology

2-Chloropyrimidine undergoes cobalt-catalyzed cross-coupling reaction with aryl halides. Safety & Documentation. Safety Information. Symbol GHS07. Signal word Warning. Hazard statements H302-H319. Precautionary statements P301 + P312 + P330-P305 + P351 + P338. Personal Protective Equipment ...

Low-cost preparation method for palbociclib

The invention relates to a low-cost preparation method for palbociclib. The low-cost preparation method comprises the following steps: by taking 2,4-dichloro-5-cyanopyrimidine as an initial raw material, performing cyano Grignard and hydrolysis so as to obtain 5-acetyl-2,4-dichloropyrimidine, protecting carbonyl, performing amination, removing carbonyl, performing acylation reaction by using diketene and amino so as to obtain 5-acetyl-4-acetoacetamide-2-chloropyrimidine, performing intramolecular dehydration on the product so as to obtain 6-acetyl-8-cyclopentyl-5-methyl-2-chlorine-8H-pyridino-[2,3-d] pyrimidine-7-ketone, protecting 6 acetyl groups by using carbonyl, further realizing reaction with an aminopyridine derivative so as to obtain 4-{6-[(6-1,1 dialkoxyl) ethyl-8-cyclopentyl-5-methyl-7-keton-7,8 dihydropyridino-[2,3-d]pyrimidine-2-amino]-pyridine-3-yl}-piperazine-1-carboxylic acid tert-butyl ester, and finally performing acid hydrolysis and neutralization to obtain palbociclib free alkali. By adopting the low-cost preparation method, the raw materials are easy to obtain, the cost is low, and the environment can be protected.
Owner:XINFA PHARMA

Preparation method for selective kinases inhibitor Palbociclib

ActiveCN105153149AAvoid Hard to Buy Hard to BuyAvoid disadvantages such as hard to getOrganic chemistryN-methylacetamideTert-Butyloxycarbonyl protecting group
The invention provides a novel preparation method for a selective kinases inhibitor Palbociclib for cyclin-dependent kinases CDK4 and CDK6, and belongs to the technical field of medicament preparation. The preparation method comprises taking 4-amino-5-bromo-2-chloropyrimidine as an initial raw material, performing acetylation with N-methoxy-N-methylacetamide to obtain an intermediate 2, performing Friedlaender reaction on the intermediate and a raw material ethyl acetoacetate to obtain an intermediate 3, and performing amino substitution on the intermediate 3 and a halogenated cyclopentane to obtain an intermediate 4; performing substitution reaction on a raw material 5-bromo-2-nitropyridine and a raw material tert-butyl 1-piperazinecarboxylate to obtain an intermediate 5, and reducing the intermediate 5 to obtain an intermediate 6; performing substitution reaction on the intermediate 4 and the intermediate 6, and performing deprotection to obtain the target product 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one with the yield of 45% or more. A brand-new route is employed, the reaction raw materials are cheap and easy to obtain, reaction conditions are mild, noble metal catalysts are avoided, and the preparation method is suitable for industrialized production.
Owner:JIANGSU ZHONGBANG PHARMA

Method for preparing rosuvastatin calcium

The invention provides a preparation method of rosuvastatin calcium. The method comprises the following steps: carrying out condensation reaction on 4-(4-fluorophenyl)-6-isopropyl-2 chloropyrimidine-5-formaldehyde and (3R)-tertiary butyl dimethylsiloxo-5-oxo-6-triphenyl phosphaalkene hexanoate; and then removing a silylether protecting group of hydroxyl, carrying out stereoselectivity reduction, reacting with 2,2-dimethoxy propane, condensing with N-methyl methane sulfonamide, removing propylidene protection, hydrolyzing an ester group, salifying and carrying out other steps, so as to obtain the rosuvastatin calcium. According to the preparation method, the yield is stable, and the price of reagents is cheap; and the method is easy to operate and is beneficial to industrial production.
Owner:ZHEJIANG JINGXIN PHARMA

Synthesis method of N-{2-[4-(2-pyrimidyl)-1-piperazine}adamantine-1-formide

The invention discloses a synthesis method of N-{2-[4-(2-pyrimidyl)-1-piperazine} adamantane-1-formide. The structural formula of the N-{2-[4-(2-pyrimidyl)-1-piperazine} adamantine-1-formide is shown in the specification. In the synthesis method, based on 2-chloropyrimidine as a main raw material, an adamantine-containing antidepressant N-{2-[4-(2-pyrimidyl)-1-piperazine} adamantane-1-formide is synthesized through nitrogen alkylation of 2-chloropyrimidine and anhydrous piperazine, alkylation of another nitrogen atom on the piperazine and bromohydrocarbon, Gabriel hydrazinolysis and amidation. The synthesis route in the invention is simple and practicable, raw material sources are abundant, reaction steps are less, and the yield of the product is high.
Owner:GUANGDONG UNIV OF TECH

Ionic iridium complex with pyrimidine ligand and preparation method thereof

The invention provides an ionic iridium complex with pyrimidine ligand and a preparation method thereof. The iridium complex has a chemical formula as follows. The preparation method of the ionic iridium complex is as below: first reacting substituted 2-chloro pyrimidine or 4,6-dimethyl pyrimidine with borophenylic acid or 2, 4-difluoro borophenylic acid to prepare a ligand; reacting the ligand with a compound iridous chloride (IrCl3.3H2O) to obtain chlorine bridge; and reacting the chlorine bridge with bisglyoxaline and conducting ion exchange reaction with salt to obtain the complex. Using iridium complex with pyrimidine derivative as an electrophosphorescent material has the following characteristics: for a same device, the pyrimidine-type iridium complex device has longer service life than a 2-phenylpyridine device; and the N atom electron cloud in the complex is more prominent, so as to increase the interaction with other molecules and improve the efficiency of energy transfer.
Owner:NINGBO UNIV

Process for synthesizing 2-chloro-pyrimidine

The invention discloses a process for synthesizing 2-chloro-pyrimidine. The process disclosed by the invention comprises the following steps: firstly, dissolving dicyandiamide into sulfuric acid at 2-6 DEG C, heating at 50-60 DEG C, and carrying out hydrolysis reaction for 4-6 hours, so as to obtain guanidine sulfate; reacting with propargyl ethyl alcohol at 50-55 DEG C for 8-12 hours, so as to obtain 2-aminopyrimidine; and finally restoring the 2-aminopyrimidine at -10 DEG C to 5 DEG C by taking NaNO2, HCl and ZnCl2 as catalysts, so as to obtain the product. Through the synthesis route, the 2-chloro-pyrimidine with relatively high purity and relatively high yield is obtained.
Owner:TAICANG YUNTONG BIOCHEM ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products